Vanguard Capital Management Reports 5.13% Passive Stake in Revolution Medicines
Revolution Medicines Inc
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Vanguard Capital Management Files Schedule 13G for Revolution Medicines, Inc. ($RVMD)
• Event Date: September 30, 2026 • Filing Date: October 30, 2026 • Shares Beneficially Owned: 10,999,044 • Ownership Percentage: 5.13% • Voting Power: 1,849,510 sole / 0 shared • Dispositive Power: 10,999,044 sole / 0 shared • Filing Rule: Rule 13d-1(b) (Passive Institutional Investor)
Comprehensive Analysis
Ownership Overview
Vanguard Capital Management filed a Schedule 13G reporting a 5.13% passive ownership stake in Revolution Medicines, Inc. (NASDAQ: RVMD) as of September 30, 2026.
Position Breakdown
- Security: Common Stock
- Aggregate Beneficial Ownership: 10,999,044 shares
- Class Percentage: 5.13%
- Sole Voting Power: 1,849,510 shares
- Shared Voting Power: 0 shares
- Sole Dispositive Power: 10,999,044 shares
- Shared Dispositive Power: 0 shares
Key Takeaways
- Filing Rule: Filed under Rule 13d-1(b), identifying the filer as a registered investment adviser holding shares in the ordinary course of business without an activist intent.
- Significance: This represents an institutional holding milestone surpassing the 5% beneficial ownership threshold. Given Vanguard's passive index and asset management nature, this filing reflects standard portfolio indexing and asset growth rather than an activist move.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.